Redmile Group, LLC - Jun 30, 2025 SCHEDULE 13G/A Report for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
RAPT
Shares outstanding
17.8M shares
Disclosed Ownership
1.77M shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 04:18 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 1.77M 0 1.77M /s/ Jeremy C. Green Managing Member
Jeremy C. Green 9.9% 1.77M 0 1.77M /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 6.5% 1.15M 0 1.15M /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.